CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 22, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and immune-oncology, today...
Hence then, the article about harbour biomed reports the online publication of phase i results for hbm9378 skb378 win378 a tslp targeting antibody was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody )
Also on site :
- Kendra Scott’s Dainty Pumpkin Necklace Is a Festive Finishing Touch for Fall Outfits, and It’s Under $35
- Dolly Parton’s Final Message to Millions of Children Is Breaking Hearts After Her Death: ‘Promise Me’
- 1969 Supergroup Ballad, the ‘Greatest Song David Crosby Ever Wrote,’ Was About Joni Mitchell and Two Other Women